Blockade of adenosine A2A receptor counteracts neuropeptide-S-induced hyperlocomotion in mice

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 381, Issue 2, 2010, Pages 153-160

  Boeck, Carina R ^a   Martinello, Caroline ^a   De Castro, Adalberto A ^a   Moretti, Morgana ^a   Dos Santos Casagrande, Tiago ^a   Guerrini, Remo ^b   Calo', Girolamo ^b   Gavioli, Elaine C ^a,c  

^a UNIVERSIDADE DO EXTREMO SUL CATARINENSE   (Brazil)

^b UNIVERSITY OF FERRARA   (Italy)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

Author keywords

Adenosine A1 receptor; Adenosine A2A receptor; Caffeine; Locomotor activity; Neuropeptide S

Indexed keywords

4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR ANTAGONIST; CAFFEINE; NEUROPEPTIDE S; NEUROTRANSMITTER; ADENOSINE A2 RECEPTOR; NEUROPEPTIDE; NEUROPEPTIDE S, HUMAN; TRIAZINE DERIVATIVE; TRIAZOLE DERIVATIVE;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DRUG MECHANISM; HYPERACTIVITY; LOCOMOTION; MOUSE; NONHUMAN; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; MALE; MOTOR ACTIVITY; MOUSE STRAIN;

ANIMALS; CAFFEINE; HUMANS; MALE; MICE; MICE, INBRED STRAINS; MOTOR ACTIVITY; NEUROPEPTIDES; RECEPTOR, ADENOSINE A1; RECEPTORS, ADENOSINE A2; TRIAZINES; TRIAZOLES;

EID: 77949273875     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-009-0480-2     Document Type: Article

References (42)

1. 2A receptors Psychopharmacology (Berl.) 183 154 162 10.1007/s00213-005-0173-6 1:CAS:528:DC%2BD2MXht1SksbbP (Pubitemid 41609267)
2. B Beck B Fernette A Stricker-Krongrad 2005 Peptide S is a novel potent inhibitor of voluntary and fast-induced food intake in rats Biochem Biophys Res Commun 332 859 865 10.1016/j.bbrc.2005.05.029 1:CAS:528:DC%2BD2MXltVKitbw%3D 15919054 (Pubitemid 40745192)
3. CR Boeck M Ganzella A Lottermann D Vendite 2004 NMDA preconditioning protects against seizures and hippocampal neurotoxicity induced by quinolinic acid in mice Epilepsia 45 7 745 750 10.1111/j.0013-9580.2004.65203.x 1:CAS:528:DC%2BD2cXmsVSnsr4%3D 15230696 (Pubitemid 38890971)
4. N Cannella D Economidou M Kallupi S Stopponi M Heilig M Massi R Ciccocioppo 2009 Persistent increase of alcohol-seeking evoked by neuropeptide s: an effect mediated by the hypothalamic hypocretin system Neuropsychopharmacology 34 9 2125 2134 10.1038/npp.2009.37 1:CAS:528: DC%2BD1MXoslyiur0%3D 19322167
5. AM Carruthers LA Sellers DW Jenkins EM Jarvie W Feniuk PP Humphrey 2001 Adenosine A(1) receptor-mediated inhibition of protein kinase A-induced calcitonin gene-related peptide release from rat trigeminal neurons Mol Pharmacol 59 1533 1541 1:CAS:528:DC%2BD3MXktVahtro%3D 11353815
6. AA Castro M Moretti TS Casagrande C Martinello F Petronilho AV Streckert R Guerrini G Calo' F Dal Pizzol J Quevedo EC Gavioli 2009 Neuropeptide S produces hyperlocomotion and prevents oxidative stress damage in the mouse brain: a comparative study with amphetamine and diazepam Pharmacol Biochem Behav 91 4 636 642 10.1016/j.pbb.2008.10.015 1:CAS:528:DC%2BD1MXhtFegtrc%3D 19022279
7. MA Cline DC Godlove W Nandar CN Bowden BC Prall 2007 Anorexigenic effects of central neuropeptide S involve the hypothalamus in chicks (Gallus gallus) Comp Biochem Physiol Part A Mol Integr Physiol 148 3 657 663 10.1016/j.cbpa.2007.08.016 (Pubitemid 47484238)
8. MA Cline BC Prall ML Smith WA Calchary PB Siegel 2008 Differential appetite-related responses to central neuropeptide S in lines of chickens divergently selected for low or high body weight J Neuroendocrinol 20 7 904 908 10.1111/j.1365-2826.2008.01742.x 1:CAS:528:DC%2BD1cXotlKitrk%3D 18445129 (Pubitemid 351859108)
9. P Correia-de-Sa JA Ribeiro 1994 Potentiation by tonic A2a-adenosine receptor activation of CGRP-facilitated: [3H]-ACh release from rat motor nerve endings Br J Pharmacol 111 582 588 1:CAS:528:DyaK2cXhvVemtb8%3D 8004402
10. M El Yacoubi C Ledent M Parmentier J Costentin JM Vaugeois 2000 The anxiogenic-like effect of caffeine in two experimental procedures measuring anxiety in the mouse is not shared by selective A(2A) adenosine receptor antagonists Psychopharmacology (Berl) 148 2 153 163 10.1007/s002130050037 1:CAS:528:DC%2BD3cXhsFCltbk%3D
11. M El Yacoubi C Ledent M Parmentier J Costentin J Vaugeois 2000 SCH 58261 and ZM 241385 differentially prevent the motor effects of CGS 21680 in mice: evidence for a functional 'atypical' adenosine A(2A) receptor Eur J Pharmacol 401 1 63 77 10.1016/S0014-2999(00)00399-X 1:CAS:528:DC%2BD3cXltVGqu7c%3D 10915839 (Pubitemid 30479814)
12. JS Fink DR Weaver SA Rivkees RA Peterfreund AE Pollack EM Adler SM Reppert 1992 Molecular cloning of the rat A2 adenosine receptor: selective co-expression with D2 dopamine receptors in rat striatum Brain Research Mol Brain Res 14 86 95
13. G Fisone A Borgkvist A Usiello 2004 Caffeine as a psychomotor stimulant: mechanism of action Cell Mol Life Sci 61 857 872 10.1007/s00018-003-3269-3 1:CAS:528:DC%2BD2cXls1Grt7k%3D 15095008 (Pubitemid 38659659)
14. C Florio AM Rosati U Traversa R Vertua 1997 Inhibitory and excitatory effects of adenosine antagonists on spontaneous locomotor activity in mice Life Sci 60 17 1477 1486 10.1016/S0024-3205(97)00099-4 1:CAS:528:DyaK2sXitFKlu7k%3D 9126868 (Pubitemid 27461304)
15. R Guerrini V Camarda C Trapella G Calo A Rizzi C Ruzza S Fiorini E Marzola R Reinscheid D Regoli S Salvadori 2009 Synthesis and biological activity of human neuropeptide S analogues modified in position 5: identification of potent and pure NPS receptor antagonists J Med Chem 52 2 524 529 10.1021/jm8012294 1:CAS:528:DC%2BD1MXntlSi 19113861
16. Guerrini R, Salvadori S, Rizzi A, Regoli D, Calo' G (2009b) Neurobiology, pharmacology, and medicinal chemistry of neuropeptide S and its receptor. Med Res Rev, doi: 10.1002/med.20180
17. RW Han XQ Yin M Chang YL Peng W Li R Wang 2009 Neuropeptide S facilitates spatial memory and mitigates spatial memory impairment induced by N-methyl-d-aspartate receptor antagonist in mice Neurosci Lett 455 1 74 77 10.1016/j.neulet.2009.03.023 1:CAS:528:DC%2BD1MXktFWktrY%3D 19429110
18. ZL Huang WM Qu N Eguchi JF Chen MA Schwarzschild BB Fredholm Y Urade O Hayaishi 2005 Adenosine A2A, but not A1, receptors mediate the arousal effect of caffeine Nat Neurosci 8 858 859 1:CAS:528:DC%2BD2MXlvFWjs74%3D 15965471
19. MF Jarvis M Williams 1989 Direct autoradiographic localization of adenosine A2 receptors in the rat brain using the A2-selective agonist, [3H]CGS 21680 Eur J Pharmacol 168 2 243 246 10.1016/0014-2999(89)90571-2 1:CAS:528:DyaL1MXlvVyit78%3D 2558026
20. K Jungling T Seidenbecher L Sosulina J Lesting S Sangha SD Clark N Okamura DM Duangdao YL Xu RK Reinscheid HC Pape 2008 Neuropeptide S-mediated control of fear expression and extinction: role of intercalated GABAergic neurons in the amygdala Neuron 59 2 298 310 10.1016/j.neuron.2008.07.002 18667157 (Pubitemid 352033690)
21. M Karcz-Kubicha K Antoniou A Terasmaa D Quarta M Solinas Z Justinova A Pezzola R Reggio CE Muller K Fuxe SR Goldberg P Popoli S Ferre 2003 Involvement of adenosine A1 and A2A receptors in the motor effects of caffeine after its acute and chronic administration Neuropsychopharmacology 28 1281 1291 10.1038/sj.npp.1300167 1:CAS:528:DC%2BD3sXkvVKmsL4%3D 12700682 (Pubitemid 41070898)
22. 2A receptor blocking agents induces caffeine-like locomotor stimulation in mice Eur Neuropsychopharmacol 16 129 136 10.1016/j.euroneuro.2005.07.001 1:CAS:528:DC%2BD28XotVCisw%3D%3D 16054807 (Pubitemid 43145819)
23. R Lage C Dieguez M Lopez 2006 Caffeine treatment regulates neuropeptide S system expression in the rat brain Neurosci Lett 410 47 51 10.1016/j.neulet. 2006.09.064 1:CAS:528:DC%2BD28XhtFKlsr3K 17055161 (Pubitemid 44667254)
24. SE Laursen JK Belknap 1986 Intracerebroventricular injections in mice. Some methodological refinements J Pharmacol Methods 16 355 357 10.1016/0160-5402(86)90038-0 1:CAS:528:DyaL2sXktlehtg%3D%3D 3784576 (Pubitemid 17189961)
25. SK Leonard JM Dwyer SJ Sukoff Rizzo B Platt SF Logue SJ Neal JE Malberg CE Beyer LE Schechter S Rosenzweig-Lipson RH Ring 2008 Pharmacology of neuropeptide S in mice: therapeutic relevance to anxiety disorders Psychopharmacology (Berl) 197 601 611 10.1007/s00213-008-1080-4 1:CAS:528:DC%2BD1cXkt1yhtr4%3D
26. W Li M Chang YL Peng YH Gao JN Zhang RW Han R Wang 2009 Neuropeptide S produces antinociceptive effects at the supraspinal level in mice Regul Pept 156 1-3 90 95 10.1016/j.regpep.2009.03.013 19345242
27. W Li YH Gao M Chang YL Peng J Yao RW Han R Wang 2009 Neuropeptide S inhibits the acquisition and the expression of conditioned place preference to morphine in mice Peptides 30 2 234 240 10.1016/j.peptides.2008.10.004 1:CAS:528:DC%2BD1MXosVSrtQ%3D%3D 18992779
28. SA Nicholson 1989 Stimulatory effect of caffeine on the hypothalamo-pituitary-adrenocortical axis in the rat J Endocrinol 122 2 535 543 10.1677/joe.0.1220535 1:CAS:528:DyaL1MXkslSqsr0%3D 2549162
29. C Pañeda S Huitron-Resendiz LM Frago JA Chowen R Picetti L de Lecea AJ Roberts 2009 Neuropeptide S reinstates cocaine-seeking behavior and increases locomotor activity through corticotropin-releasing factor receptor 1 in mice J Neurosci 29 13 4155 4161 10.1523/JNEUROSCI.5256-08.2009 19339610
30. N Okamura SA Habay J Zeng AR Chamberlin RK Reinscheid 2008 Synthesis and pharmacological in vitro and in vivo profile of 3-oxo-1,1-diphenyl-tetrahydro- oxazolo[3, 4-a]pyrazine-7-carboxylic acid 4-fluoro-benzylamide (SHA 68), a selective antagonist of the neuropeptide S receptor J Pharmacol Exp Ther 325 893 901 10.1124/jpet.107.135103 1:CAS:528:DC%2BD1cXmsVOrt7o%3D 18337476 (Pubitemid 351724341)
31. L Raiteri E Luccini C Romei S Salvadori G Calò 2009 Neuropeptide S selectively inhibits the release of 5-HT and noradrenaline from mouse frontal cortex nerve endings Br J Pharmacol 157 3 474 481 10.1111/j.1476-5381.2009. 00163.x 1:CAS:528:DC%2BD1MXnt1Ggtro%3D 19371348
32. RK Reinscheid YL Xu N Okamura J Zeng S Chung R Pai Z Wang O Civelli 2005 Pharmacological characterization of human and murine neuropeptide s receptor variants J Pharmacol Exp Ther 315 1338 1345 10.1124/jpet.105.093427 1:CAS:528:DC%2BD2MXhtlalurbK 16144971 (Pubitemid 41635423)
33. SA Rivkees SL Price FC Zhou 1995 Immunohistochemical detection of A1 adenosine receptors in rat brain with emphasis on localization in the hippocampal formation, cerebral cortex, cerebellum, and basal ganglia Brain Res 677 193 203 10.1016/0006-8993(95)00062-U 1:CAS:528:DyaK2MXlt1Sqtro%3D 7552243
34. A Rizzi R Vergura G Marzola C Ruzza R Guerrini S Salvadori D Regoli G Calo 2008 Neuropeptide S is a stimulatory anxiolytic agent: a behavioural study in mice Br J Pharmacol 154 471 479 10.1038/bjp.2008.96 1:CAS:528: DC%2BD1cXlvVWnsrk%3D 18376418 (Pubitemid 351670609)
35. AL Roth E Marzola A Rizzi M Arduin C Trapella C Corti R Vergura P Martinelli S Salvadori D Regoli M Corsi P Cavanni G Calo' R Guerrini 2006 Structure-activity studies on neuropeptide S: identification of the amino acid residues crucial for receptor activation J Biol Chem 281 20809 20816 10.1074/jbc.M601846200 1:CAS:528:DC%2BD28Xnt1GqtL4%3D 16720571 (Pubitemid 44115422)
36. AM Sebastião JA Ribeiro 2000 Fine-tuning neuromodulation by adenosine Trends Pharmacol Sci 21 9 341 346 10.1016/S0165-6147(00)01517-0 10973087 (Pubitemid 30649669)
37. AM Sebastião MP Macedo JA Ribeiro 2000 Tonic activation of A(2A) adenosine receptors unmasks, and of A(1) receptors prevents, a facilitatory action of calcitonin gene-related peptide in the rat hippocampus Br J Pharmacol 129 374 380 10.1038/sj.bjp.0703048 10694245
38. KL Smith M Patterson WS Dhillo SR Patel NM Semjonous JV Gardiner MA Ghatei SR Bloom 2006 Neuropeptide S stimulates the hypothalamo-pituitaryadrenal axis and inhibits food intake Endocrinology 147 3510 3508 10.1210/en.2005-1280 1:CAS:528:DC%2BD28XmtlOrsb4%3D 16574794 (Pubitemid 43901142)
39. P Svenningsson GG Nomikos E Ongini BB Fredholm 1997 Antagonism of adenosine A2A receptors underlies the behavioural activating effect of caffeine and is associated with reduced expression of messenger RNA for NGFI-A and NGFI-B in caudate-putamen and nucleus accumbens Neuroscience 79 753 764 10.1016/S0306-4522(97)00046-8 1:CAS:528:DyaK2sXktlWnt7s%3D 9219939 (Pubitemid 27292672)
40. G Vitale M Filaferro V Ruggieri S Pennella C Frigeri A Rizzi R Guerrini G Calo 2008 Anxiolytic-like effect of neuropeptide S in the rat defensive burying Peptides 29 2286 2291 10.1016/j.peptides.2008.08.014 1:CAS:528: DC%2BD1cXhtl2qtrrJ 18793688 (Pubitemid 50287237)
41. YL Xu RK Reinscheid S Huitron-Resendiz SD Clark Z Wang SH Lin FA Brucher J Zeng NK Ly SJ Henriksen L de Lecea O Civelli 2004 Neuropeptide S: a neuropeptide promoting arousal and anxiolytic-like effects Neuron 43 487 497 10.1016/j.neuron.2004.08.005 1:CAS:528:DC%2BD2cXnsVeitb0%3D 15312648 (Pubitemid 39094676)
42. YL Xu CM Gall VR Jackson O Civelli RK Reinscheid 2007 Distribution of neuropeptide S receptor mRNA and neurochemical characteristics of neuropeptide S-expressing neurons in the rat brain J Comp Neurol 500 84 102 10.1002/cne.21159 1:CAS:528:DC%2BD2sXktlCrtQ%3D%3D 17099900 (Pubitemid 44904303)